Features of Maturation of Dendritic Cells from Monocytes Depending on HER2 Status of Breast Cancer.

IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
A S Golderova, I E Nikolaeva
{"title":"Features of Maturation of Dendritic Cells from Monocytes Depending on HER2 Status of Breast Cancer.","authors":"A S Golderova, I E Nikolaeva","doi":"10.1007/s10517-025-06434-7","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, we analyzed the features of maturation of dendritic cell depending on the HER2 status of breast cancer based on morphology and immunophenotyping. Monocytes were isolated from the venous blood of 12 women with breast cancer: 4 patients with HER2<sup>-</sup> status and 8 with HER2<sup>+</sup> status. In patients with HER2<sup>-</sup> status, significantly lower (p = 0.029) expression of costimulatory membrane signal CD86 on dendritic cells on day 9 of culturing and reduced (p = 0.03) number of stretched cells on day 2 of culturing were revealed. Additionally, a correlation (r = 510; p = 0.031) was found between HER2<sup>+</sup> status and the number of round immature cells on day 7 of culturing. The results indicate that maturation of dendritic cells from peripheral blood monocytes from HER2<sup>+</sup> status breast cancer patients is less active and incomplete on the first and last days in culture compared to cells from HER2<sup>-</sup> patients. Low expression of CD86 costimulatory signal can be the cause of impaired antigen-presenting function of dendritic cells, which indirectly confirms aggressiveness of HER2<sup>+</sup> breast cancer.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"78-80"},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06434-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we analyzed the features of maturation of dendritic cell depending on the HER2 status of breast cancer based on morphology and immunophenotyping. Monocytes were isolated from the venous blood of 12 women with breast cancer: 4 patients with HER2- status and 8 with HER2+ status. In patients with HER2- status, significantly lower (p = 0.029) expression of costimulatory membrane signal CD86 on dendritic cells on day 9 of culturing and reduced (p = 0.03) number of stretched cells on day 2 of culturing were revealed. Additionally, a correlation (r = 510; p = 0.031) was found between HER2+ status and the number of round immature cells on day 7 of culturing. The results indicate that maturation of dendritic cells from peripheral blood monocytes from HER2+ status breast cancer patients is less active and incomplete on the first and last days in culture compared to cells from HER2- patients. Low expression of CD86 costimulatory signal can be the cause of impaired antigen-presenting function of dendritic cells, which indirectly confirms aggressiveness of HER2+ breast cancer.

乳腺癌中HER2状态对单核细胞树突状细胞成熟的影响
在本研究中,我们基于形态学和免疫表型分析了树突状细胞成熟依赖于乳腺癌HER2状态的特征。从12例乳腺癌女性静脉血中分离出单核细胞,其中4例为HER2-状态,8例为HER2+状态。HER2-状态患者在培养第9天树突状细胞上共刺激膜信号CD86的表达显著降低(p = 0.029),在培养第2天树突状细胞拉伸数量显著减少(p = 0.03)。此外,相关性(r = 510;p = 0.031),在培养第7天,HER2+状态与圆形未成熟细胞数量之间存在显著性差异。结果表明,与HER2阳性乳腺癌患者的细胞相比,HER2阳性乳腺癌患者外周血单核细胞的树突状细胞在培养的第一天和最后一天的成熟活性较低,且不完整。CD86共刺激信号的低表达可能是树突状细胞抗原呈递功能受损的原因,间接证实了HER2+乳腺癌的侵袭性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine 医学-医学:研究与实验
CiteScore
1.50
自引率
14.30%
发文量
265
审稿时长
2 months
期刊介绍: Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005. World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells. The Russian Volume Year is published in English from April.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信